NASDAQ$NRC

NRC Health · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Announced first quarter 2023 results, focusing on enabling healthcare organizations to deliver personalized care and expanding sales and marketing resources.

NRC Health announced its first quarter 2023 results, with a focus on personalized care and expanding sales and marketing resources. The company funded innovation and growth, dividend payments, and share repurchases during the quarter. Diluted earnings per share decreased compared to the same period last year.

  • Focused on enabling healthcare organizations to deliver personalized care.
  • Expanding sales and marketing resources to increase awareness and adoption of the Human Understanding Program.
  • Board of Directors maintained capital allocation priorities of funding innovation and growth investments, shareholder dividends and share repurchases.
  • Diluted earnings per share decreased to $0.28 for the quarter ended March 31, 2023, from diluted earnings per share of $0.34 for the quarter ended March 31, 2022.

Headline financials

Total Revenue

$36.5M

Previous: $38.4M-5.1%
EPS (adj)

$0.28

Previous: $0.34-17.6%
Capital Expenditures

-$3.2M

Previous: -$2.54M-25.8%
Free Cash Flow

$3.77M

Previous: $6M-37.2%
Net Income

$6.96M

Previous: $8.54M-18.4%
Operating Income

$9.02M

Previous: $11.7M-22.9%
Gross Profit

-$14.3M

Previous: -$14.8M+3.4%
Cash & Equivalents

$23.7M

Previous: $47.3M-49.8%
Total Assets

$134M

Previous: $153M-12.3%
Stock-Based Comp

$304K

Previous: $285K+6.7%

Revenue & EPS history

NRC · Revenue · Quarterly

$36.5M

Q1 2023-5.1%vs Q1 2022

Forward guidance

No specific forward guidance provided in the press release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-0.9%

Avg return

Earnings day

-0.9%

Avg return

5 days after

-0.3%

Avg return

30 days after

54%

28 / 52 earnings

Positive

+16.1%

Q3 2025

Best reaction

-19.9%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.6%+7.9%+16.0%
Q4 2025-19.9%-27.2%-35.9%
Q3 2025+16.1%+17.0%+51.2%
Q2 2025+2.1%+4.8%+6.7%
Q1 2025+7.0%+7.6%+20.2%
Q4 2024-11.9%-11.0%-22.6%
Q3 2024+2.6%-2.1%+4.5%
Q2 2024-11.7%-9.3%-7.2%
Q1 2024-15.3%-11.6%-23.7%
Q4 2023+2.2%+0.6%+1.7%
Q3 2023-1.9%-0.3%-1.1%
Q2 2023+2.2%-0.4%-2.6%
Q1 2023-8.3%-5.2%-1.2%
Q4 2022+4.8%+5.3%-1.8%
Q3 2022-13.5%-8.3%-3.5%
Q2 2022-4.1%-7.4%-12.8%
Q1 2022-5.3%-3.6%+5.0%
Q4 2021-1.5%-4.5%-4.7%
Q3 2021+6.7%+6.7%-8.1%
Q2 2021-0.8%-0.2%+1.6%
Q1 2021-10.2%-5.1%-7.0%
Q4 2020-0.7%-3.9%+0.3%
Q3 2020+1.8%-0.1%-7.8%
Q2 2020-4.1%-1.0%-3.0%
Q1 2020+4.6%+10.3%+12.7%
Q4 2019+0.3%+1.8%-36.0%
Q3 2019-0.4%+0.2%+7.5%
Q2 2019+3.0%+2.6%+1.0%
Q1 2019+7.1%+13.1%+26.5%
Q4 2018+0.6%+2.7%+0.2%
Q3 2018+3.5%+2.4%+4.8%
Q2 2018-0.3%-0.3%+2.4%
Q1 2018+7.3%+5.5%+5.4%
Q4 2017-7.4%-7.9%-9.7%
Q3 2017-10.1%-11.5%-7.7%
Q2 2017+0.9%+1.7%+9.9%
Q1 2017+0.8%-3.4%-3.0%
Q4 2016-3.0%-4.9%+0.5%
Q3 2016-4.6%-1.0%+5.2%
Q2 2016+0.3%+2.3%+2.2%
Q1 2016+2.0%
Q4 2015+0.6%
Q3 2015+1.5%
Q2 2015-2.4%
Q1 2015+1.3%
Q4 2014-0.8%
Q3 2014+0.9%
Q2 2014+3.8%
Q1 2014+3.9%
Q4 2013+5.1%
Q3 2013+1.0%
Q2 2013-1.2%
Q1 2013
Q4 2012
Q2 2010
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q1 2011
Q3 2011
Q3 2010
Q4 2009
Q2 2011
Q4 2010
Q1 2010

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro